An insight into the TAM system in Alzheimer?s disease

被引:8
|
作者
Zhou, Shiqi [1 ]
Li, Yanyan [1 ]
Zhang, Zhao [1 ]
Yuan, Yuhe [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
[2] Chinese850 Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Dept Pharmacol, I Xiannongtan St, Beijing 100050, Peoples R China
基金
北京市自然科学基金;
关键词
TAM system; Neuroinflammation; Microglia; A; Biomarker; Alzheimer?s disease; RECEPTOR TYROSINE KINASES; PROTEIN-S; VITAMIN-K; APOPTOTIC CELLS; IMMUNE-SYSTEM; SOLUBLE FORM; GAS6; BRAIN; AXL; MICROGLIA;
D O I
10.1016/j.intimp.2023.109791
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TAM receptors may help delay the progression of Alzheimer's disease (AD). AD is the most common neurodegenerative disease associated with human aging. The TAM receptors, derived from the first letter of its three constituents -Tyro3, Axl, and Mertk, are associated with immune responses, cellular differentiation and migration, and clearance of apoptotic cells and debris, with the two canonical ligands, Growth Arrest Specific 6 (Gas6) and ProS1. Several kinds of research have indicated the participation of the TAM system in AD pathology. Also, the TAMs regulate multiple features of microglia, the significant sensors of disorder in the central nervous system (CNS).In this review, we describe the biology of the TAM receptors and ligands in the CNS. Then, we discuss the relationship between the TAM system and AD, specially focusing on its functional expression in the microglia. Finally, we also summarize some agents that could interfere with the TAM signaling pathways and discuss potential difficulties and strategies for drug development.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The Ubiquitin System in Alzheimer's Disease
    Harris, Lee D.
    Jasem, Sarah
    Licchesi, Julien D. F.
    PROTEOSTASIS AND DISEASE: FROM BASIC MECHANISMS TO CLINICS, 2020, 1233 : 195 - 221
  • [32] The endocannabinoid system and Alzheimer's disease
    Benito, Cristina
    Nunez, Estefania
    Pazos, Maria Ruth
    Tolon, Rosa Maria
    Romero, Julian
    MOLECULAR NEUROBIOLOGY, 2007, 36 (01) : 75 - 81
  • [33] The Endocannabinoid System and Alzheimer’s Disease
    Cristina Benito
    Estefanía Núñez
    María Ruth Pazos
    Rosa María Tolón
    Julián Romero
    Molecular Neurobiology, 2007, 36 : 75 - 81
  • [34] Adrenergic system in Alzheimer's disease
    Femminella, G. D.
    Edison, P.
    GIORNALE DI GERONTOLOGIA, 2015, 63 (02) : 121 - 127
  • [35] The visual system in Alzheimer's disease
    Reyes, P
    Nygaard, H
    Golden, G
    Pedersen, W
    Grigaitis, M
    JOURNAL OF NEUROLOGY, 2004, 251 : 37 - 37
  • [36] Ghrelin system in Alzheimer?s disease
    Tian, Jing
    Wang, Tienju
    Du, Heng
    CURRENT OPINION IN NEUROBIOLOGY, 2023, 78
  • [37] The cholinergic system in Alzheimer's disease
    Steur, ENHJ
    Wevers, A
    CURRENT OPINION IN PSYCHIATRY, 2002, 15 (03) : 279 - 284
  • [38] Opioid System and Alzheimer’s Disease
    Zhiyou Cai
    Anna Ratka
    NeuroMolecular Medicine, 2012, 14 : 91 - 111
  • [39] The cholinergic system in Alzheimer's disease
    Kasa, P
    Rakonczay, Z
    Gulya, K
    PROGRESS IN NEUROBIOLOGY, 1997, 52 (06) : 511 - 535
  • [40] The dopaminergic system and Alzheimer's disease
    Zhang, Yuhan
    Liang, Yuan
    Gu, Yixue
    NEURAL REGENERATION RESEARCH, 2025, 20 (09) : 2495 - 2512